Treatment of hemophilia B with a new clotting-factor concentrate.
D000293:Adolescent; D000328:Adult; D001779:Blood Coagulation Factors / Q000032:analysis / Q000378:metabolism / Q000627:therapeutic use*; D001780:Blood Coagulation Tests; D001798:Blood Proteins / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D005164:Factor IX / Q000378:metabolism / Q000627:therapeutic use*; D005167:Factor VII / Q000378:metabolism / Q000627:therapeutic use*; D005170:Factor X / Q000378:metabolism / Q000627:therapeutic use*; D002836:Hemophilia B / Q000188:drug therapy*; D006801:Humans; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D008297:Male; D008722:Methods; D008875:Middle Aged; D010958:Plasminogen / Q000032:analysis
D001779:Blood Coagulation Factors; D001798:Blood Proteins; D005167:Factor VII; D005164:Factor IX; D005170:Factor X; D010958:Plasminogen